Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MALIGNANT ASCITES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 92 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Levitt, NC; Eskens, FALM; O'Byrne, KJ; Propper, DJ; Denis, LJ; Owen, SJ; Choi, L; Foekens, JA; Wilner, S; Wood, JM; Nakajima, M; Talbot, DC; Steward, WP; Harris, AL; Verweij, J
      Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer

      CLINICAL CANCER RESEARCH
    2. Tanemura, M; Nishikawa, N; Kojima, K; Suzuki, Y; Suzumori, K
      A case of successful fetal therapy for congenital chylothorax by intrapleural injection of OK-432

      ULTRASOUND IN OBSTETRICS & GYNECOLOGY
    3. McQuellon, RP; Loggie, BW; Fleming, RA; Russell, GB; Lehman, AB; Rambo, TD
      Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) forperitoneal carcinomatosis

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    4. Melichar, B; Touskova, M; Tosner, J; Kopecky, O
      The phenotype of ascitic fluid lymphocytes in patients with ovarian carcinoma and other primaries

      ONKOLOGIE
    5. Sartori, S; Nielsen, I; Tassinari, D; Trevisani, L; Abbasciano, V; Malacarne, P
      Evaluation of a standardized protocol of intracavitary recombinant interferon alpha-2b in the palliative treatment of malignant peritoneal effusions - A prospective pilot study

      ONCOLOGY
    6. Bieligk, SC; Calvo, BF; Coit, DG
      Peritoneovenous shunting for nongynecologic malignant ascites

      CANCER
    7. Smeak, DD; Birchard, SJ; McLoughlin, MA; Lindsey, MM; Holt, DE; Caywood, DD; Downs, MO
      Treatment of chronic pleural effusion with pleuroperitoneal shunts in dogs: 14 cases (1985-1999)

      JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
    8. Zervos, EE; Rosemurgy, AS
      Management of medically refractory ascites

      AMERICAN JOURNAL OF SURGERY
    9. Feldman, AL; Alexander, HR; Hewitt, SM; Lorang, D; Thiruvathukal, CE; Turner, EM; Libutti, SK
      Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of murine tumors

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    10. Freedman, RS; Kudelka, AP; Kavanagh, JJ; Verschraegen, C; Edwards, CL; Nash, M; Levy, L; Atkinson, EN; Zhang, HZ; Melichar, B; Patenia, R; Templin, S; Scott, W; Platsoucas, CD
      Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma

      CLINICAL CANCER RESEARCH
    11. Xu, L; Yoneda, J; Herrera, C; Wood, J; Killion, JJ; Fidler, IJ
      Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growthfactor receptor tyrosine kinases

      INTERNATIONAL JOURNAL OF ONCOLOGY
    12. Lee, A; Lau, TN; Yeong, KY
      Indwelling catheters for the management of malignant ascites

      SUPPORTIVE CARE IN CANCER
    13. Mackey, JR; Wood, L; Nabholtz, JM; Jensen, J; Venner, P
      A phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    14. Andersson, H; Lindegren, S; Back, T; Jacobsson, L; Leser, G; Horvath, G
      The curative and palliative potential of the monoclonal antibody MOv18 labelled with At-211 in nude mice with intraperitoneally growing ovarian cancer xenografts - A long-term study

      ACTA ONCOLOGICA
    15. McNamara, P
      Paracentesis - an effective method of symptom control in the palliative care setting?

      PALLIATIVE MEDICINE
    16. Morisaki, T; Matsunaga, H; Beppu, K; Ihara, E; Hirano, K; Kanaide, H; Mori, M; Katano, M
      A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) iduces apoptosis in human gastric carcinoma cells

      ANTICANCER RESEARCH
    17. Tueche, SG; Pector, JC
      Peritoneovenous shunt in malignant ascites. The Bordet Institute Experience from 1975-1998

      HEPATO-GASTROENTEROLOGY
    18. Toyokawa, Y; Kuriyama, S; Tsujinoue, H; Nakatani, T; Mitoro, A; Yoshiji, H; Fukui, H
      Retrovirus-mediated in vivo gene therapy using the herpes simplex virus thymidine kinase gene against carcinomatous peritonitis

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    19. Loggie, BW; Fleming, RA; McQuellon, RP; Russell, GB; Geisinger, KR
      Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin

      AMERICAN SURGEON
    20. Roskos, M; Popp, MB
      Laparoscopic diagnosis and management of malignant ascites

      SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES
    21. Lewin, M; de Baere, T; Lagrange, C; Lhomme, C; Pautier, P; Roche, A
      Cystogastric transmural drainage for the treatment of symptomatic cystic metastases from ovarian carcinoma

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    22. Halperin, R; Hadas, E; Langer, R; Bukovsky, I; Schneider, D
      Peritoneal fluid gonadotropins and ovarian hormones in patients with ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    23. Halperin, R; Hadas, E; Bukovsky, I; Schneider, D
      Peritoneal fluid analysis in the differentiation of ovarian cancer and benign ovarian tumor

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    24. Kim, DK; Lee, TV; Castilleja, A; Anderson, BW; Peoples, GE; Kudelka, AP; Murray, JL; Sittisomwong, T; Wharton, JT; Kim, JW; Ioannides, CG
      Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients

      ANTICANCER RESEARCH
    25. HUDSON JM; CASTILLEJA A; MURRAY JL; HONDA T; KUDELKA A; SINGLETARY E; WHARTON JT; IOANNIDES CG
      GROWTH AND ANTIGEN RECOGNITION OF TUMOR-INFILTRATING LYMPHOCYTES FROMHUMAN BREAST-CANCER

      Journal of interferon & cytokine research
    26. Peoples, GE; Anderson, BW; Fisk, B; Kudelka, AP; Wharton, JT; Ioannides, CG
      Ovarian cancer-associated lymphocyte recognition of folate binding proteinpeptides

      ANNALS OF SURGICAL ONCOLOGY
    27. BAXEVANIS CN; VOUTSAS LF; SOLER MH; GRITZAPIS AD; TSITSILONIS OE; STOEVA S; VOELTER W; ARSENIS P; PAPAMICHAIL M
      MISTLETOE LECTIN I-INDUCED EFFECTS ON HUMAN CYTOTOXIC LYMPHOCYTES - I- SYNERGISM WITH IL-2 IN THE INDUCTION OF ENHANCED LAK CYTOTOXICITY

      Immunopharmacology and immunotoxicology
    28. MERCADANTE S; LAROSA S; NICOLOSI G; GAROFALO SL
      TEMPORARY DRAINAGE OF SYMPTOMATIC MALIGNANT ASCITES BY A CATHETER INSERTED UNDER COMPUTERIZED-TOMOGRAPHY

      Journal of pain and symptom management
    29. LUO JC; TOYODA M; SHIBUYA M
      DIFFERENTIAL INHIBITION OF FLUID ACCUMULATION AND TUMOR-GROWTH IN 2 MOUSE ASCITES TUMORS BY AN ANTIVASCULAR ENDOTHELIAL GROWTH-FACTOR PERMEABILITY FACTOR NEUTRALIZING ANTIBODY

      Cancer research
    30. NOGUCHI K; TANIMURA H; YAMAUE H; IWAHASHI M; TSUNODA T; TANI M; HOTTA T; MIZOBATA S; ARII K; TAMAI M
      CISPLATIN MODULATES TUMOR-CELL SUSCEPTIBILITY TO TUMOR-INFILTRATING LYMPHOCYTES IN-VIVO

      Oncology Reports
    31. WAKASUGI T; TAKEDA T; MONDEN T; KATSUMOTO Y; SAKITA I; NAGAOKA H; FUKUNAGA M; TOMITA N; KOBAYASHI T; SHIOZAKI H; SHIMANO T; MONDEN M
      AUGMENTATION OF SPLENIC ANTITUMOR IMMUNITY BY LOCAL IMMUNOTHERAPY IN GASTRIC-CANCER PATIENTS

      Biotherapy
    32. PARSONS SL; WATSON SA; STEELE RJC
      PHASE I II TRIAL OF BATIMASTAT, A MATRIX METALLOPROTEINASE INHIBITOR,IN PATIENTS WITH MALIGNANT ASCITES/

      European journal of surgical oncology
    33. BOMBARDIERI E; FERRARI L; SPINELLI A; MAFFIOLI L; SEREGNI E; BURAGGI G
      RADIOIMMUNOTHERAPY OF OVARIAN-CANCER WITH RADIOLABELED MONOCLONAL-ANTIBODIES - BIOLOGICAL BASIS, PRESENT STATUS AND FUTURE PERSPECTIVES

      Anticancer research
    34. ISHIKO T; SAKAMOTO K; MITA S; KAMOHARA H; OGAWA M
      EVIDENCE THAT EOSINOPHIL INFILTRATION IN THE OK-432 FIBRINOGEN-INJECTED METH-A TUMOR IN MICE IS MEDIATED BY LOCALLY PRODUCED IL-5/

      International journal of immunopharmacology
    35. HIRTE HW; MILLER D; TONKIN K; FINDLAY B; CAPSTICK V; MURPHY J; BUCKMAN R; CARMICHAEL J; LEVINE M; HILL W
      A RANDOMIZED TRIAL OF PARACENTESIS PLUS INTRAPERITONEAL TUMOR-NECROSIS-FACTOR-ALPHA VERSUS PARACENTESIS ALONE IN PATIENTS WITH SYMPTOMATIC ASCITES FROM RECURRENT OVARIAN-CARCINOMA

      Gynecologic oncology
    36. AOYAGI H; IINO Y; TAKEO T; HORII Y; MORISHITA Y; HORIUCHI R
      EFFECTS OF OK-432 (PICIBANIL) ON THE ESTROGEN-RECEPTORS OF MCF-7 CELLS AND POTENTIATION OF ANTIPROLIFERATIVE EFFECTS OF TAMOXIFEN IN COMBINATION WITH OK-432

      Oncology
    37. LAMERS CHJ; BOLHUIS RLH; WARNAAR SO; STOTER G; GRATAMA JW
      LOCAL BUT NO SYSTEMIC IMMUNOMODULATION BY INTRAPERITONEAL TREATMENT OF ADVANCED OVARIAN-CANCER WITH AUTOLOGOUS T-LYMPHOCYTES RE-TARGETED BYA BI-SPECIFIC MONOCLONAL-ANTIBODY

      International journal of cancer
    38. MANTOVANI G; MACCIO A; PISANO M; VERSACE R; LAI P; ESU S; MASSA E; GHIANI M; DESSI D; MELIS GB; DELGIACCO GS
      TUMOR-ASSOCIATED LYMPHO-MONOCYTES FROM NEOPLASTIC EFFUSIONS ARE IMMUNOLOGICALLY DEFECTIVE IN COMPARISON WITH PATIENT AUTOLOGOUS PBMCS BUT ARE CAPABLE OF RELEASING HIGH AMOUNTS OF VARIOUS CYTOKINES

      International journal of cancer
    39. MANNELLO F; MIRAGOLI G; BIANCHI G; GAZZANELLI G
      PROSTATE-SPECIFIC ANTIGEN IN ASCITIC FLUID

      Clinical chemistry
    40. SALVATORE F; SACCHETTI L; CASTALDO G
      MULTIVARIATE DISCRIMINANT-ANALYSIS OF BIOCHEMICAL PARAMETERS FOR THE DIFFERENTIATION OF CLINICALLY CONFOUNDING LIVER-DISEASES

      Clinica chimica acta
    41. FISK B; ANDERSON BW; GRAVITT KR; OBRIAN CA; KUDELKA AP; MURRAY JL; WHARTON JT; IOANNIDES CG
      IDENTIFICATION OF NATURALLY PROCESSED HUMAN OVARIAN PEPTIDES RECOGNIZED BY TUMOR-ASSOCIATED CD8(-LYMPHOCYTES() CYTOTOXIC T)

      Cancer research
    42. PORCEL A; ALCAIN G; MORENO M; AMAYA A; GUILLEN P; MARTIN L
      THE VALUE OF LAPAROSCOPY IN ASCITES OF UN KNOWN ORIGIN

      Revista espanola de enfermedades digestivas
    43. BEHAMMER W; KLUGE M; RUSCHOFF J; MANNEL DN
      TUMOR-NECROSIS-FACTOR EFFECTS ON ASCITES FORMATION IN AN EXPERIMENTALTUMOR-MODEL

      Journal of interferon & cytokine research
    44. KATO H; INOUE M; MUKAI S; KAWAHITO Y; YOSHIDA T; ASAI K; KIMURA S; HASHIRAMOTO A; YAMAMURA Y; SANO H; SUGINO S; KONDO M
      MORPHOLOGICAL-STUDY OF CYTOTOXICITY PRODUCED BY PSK-INDUCED POLYMORPHONUCLEAR LEUKOCYTES (PMNS) AND NOCARDIA-RUBRA CELL-WALL SKELETON

      Biotherapy
    45. OTT MG; MANNEL DN; GALLATI H; GOERIG M; RAETH U
      PERIPHERAL NATURAL-KILLER-CELL ACTIVITY AND INTRAPERITONEAL SOLUBLE P55 TUMOR-NECROSIS-FACTOR RECEPTOR IN PATIENTS WITH MALIGNANT ASCITES -2 POSSIBLE INDICATORS FOR RESPONSE TO INTRAPERITONEAL COMBINED TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA TREATMENT

      Cancer immunology and immunotherapy
    46. YAZDI GP; MIEDEMA BW; HUMPHREY LJ
      HIGH MORTALITY AFTER ABDOMINAL OPERATION IN PATIENTS WITH LARGE-VOLUME MALIGNANT ASCITES

      Journal of surgical oncology
    47. CASTALDO G; INTRIERI M; CALCAGNO G; CIMINO L; BUDILLON G; SACCHETTI L; SALVATORE F
      ASCITIC PSEUDOURIDINE DISCRIMINATES BETWEEN HEPATOCARCINOMA-DERIVED ASCITES AND CIRRHOTIC ASCITES

      Clinical chemistry
    48. KATSUMOTO Y; MONDEN T; TAKEDA T; HABA A; ITO Y; WAKASUGI E; WAKASUGI E; WAKASUGI T; SEKIMOTO M; KOBAYASHI T; SHIOZAKI H; SHIMANO T; MONDEN M
      ANALYSIS OF CYTOTOXIC ACTIVITY OF THE CD4(-LYMPHOCYTES GENERATED BY LOCAL IMMUNOTHERAPY() T)

      British Journal of Cancer
    49. ARCHIMANDRITIS A; KAPSALAS D; DOUVARA M; TJIVRAS M; TSIRANTONAKI M; FERTAKIS A
      VALUE OF ASCITIC FIBRONECTIN AND CHOLESTEROL CONCENTRATION IN THE DIFFERENTIATION BETWEEN MALIGNANCY-RELATED AND NONMALIGNANT ASCITES

      Annales de medecine interne
    50. LOGGIE BW; FLEMING RA; GEISINGER KR
      CYTOLOGIC ASSESSMENT BEFORE AND AFTER INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY FOR PERITONEAL CARCINOMATOSIS

      Acta cytologica
    51. SANCHEZLOMBRANA JL; DELAVEGA J; FERNANDEZ E; LINARES A; PEREZ R; RODRIGUEZ M; RODRIGO L
      CHARACTERISTICS OF ASCITIC FLUID IN OVARIAN CARCINOMATOSIS

      Revista espanola de enfermedades digestivas
    52. FISK B; SAVARY C; HUDSON JM; OBRIAN CA; MURRAY JL; WHARTON JT; IOANNIDES CG
      CHANGES IN AN HER-2 PEPTIDE UP-REGULATING HLA-A2 EXPRESSION AFFECT BOTH CONFORMATIONAL EPITOPES AND CTL RECOGNITION - IMPLICATIONS FOR OPTIMIZATION OF ANTIGEN PRESENTATION AND TUMOR-SPECIFIC CTL INDUCTION

      Journal of immunotherapy with emphasis on tumor immunology
    53. KUIPER M; PEAKMAN M; FARZANEH F
      OVARIAN TUMOR-ANTIGENS AS POTENTIAL TARGETS FOR IMMUNE GENE-THERAPY

      Gene therapy
    54. SHARMA S; WALSH D
      MANAGEMENT OF SYMPTOMATIC MALIGNANT ASCITES WITH DIURETICS - 2 CASE-REPORTS AND A REVIEW OF THE LITERATURE

      Journal of pain and symptom management
    55. GUPTA R; MISRA SP; DWIVEDI M; MISRA V; KUMAR S; GUPTA SC
      DIAGNOSING ASCITES - VALUE OF ASCITIC FLUID TOTAL PROTEIN, ALBUMIN, CHOLESTEROL, THEIR RATIOS, SERUM-ASCITES ALBUMIN AND CHOLESTEROL GRADIENT

      Journal of gastroenterology and hepatology
    56. IMBERTMARCILLE BM; BERREUR M; THEDREZ P; RIET A; DEVYS A; CHATAL JF; PRADAL G
      EFFECTS OF INTERFERON-GAMMA (IFN-GAMMA) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) ASSOCIATION IN INTRAPERITONEAL RADIOIMMUNOTHERAPY - STUDIES ON AN IN-VITRO MICROMETASTASIS MODEL

      Anti-cancer drug design
    57. YAMAGUCHI Y; SATOH Y; MIYAHARA E; NOMA K; FUNAKOSHI M; TAKASHIMA I; SAWAMURA A; TOGE T
      LOCOREGIONAL IMMUNOTHERAPY OF MALIGNANT ASCITES BY INTRAPERITONEAL ADMINISTRATION OF OK-432 PLUS IL-2 IN GASTRIC-CANCER PATIENTS

      Anticancer research
    58. BUO L; KARLSRUD TS; DYRHAUG G; BELL H; ENGSTROM L; JOHANSEN HT; AASEN AO
      THE FIBRINOLYTIC SYSTEM IN HUMAN ASCITES

      Scandinavian journal of gastroenterology
    59. CASTALDO G; CASTELLANO L; DESIO I; MOSTARDA I; CIMINO L; BUDILLON G; SACCHETTI L; LOGUERCIO C; BLANCO CDV; SALVATORE F
      EARLY BIOCHEMICAL-EVIDENCE OF NEOPLASM IN A CASE OF ASCITES OF UNKNOWN ORIGIN

      Clinical chemistry
    60. GRECO AV; MINGRONE G; GASBARRINI G
      FREE FATTY-ACID ANALYSIS IN ASCITIC FLUID IMPROVES DIAGNOSIS IN MALIGNANT ABDOMINAL-TUMORS

      Clinica chimica acta
    61. NAGY JA; MORGAN ES; HERZBERG KT; MANSEAU EJ; DVORAK AM; DVORAK HF
      PATHOGENESIS OF ASCITES TUMOR-GROWTH - ANGIOGENESIS, VASCULAR REMODELING, AND STROMA FORMATION IN THE PERITONEAL LINING

      Cancer research
    62. MUKAI M; KUBOTA S; MORITA S; AKANUMA A
      A PILOT-STUDY OF COMBINATION THERAPY OF RADIATION AND LOCAL-ADMINISTRATION OF OK-432 FOR ESOPHAGEAL-CANCER - 5-YEAR SURVIVAL AND LOCAL-CONTROL RATE

      Cancer
    63. CANEVARI S; STOTER G; ARIENTI F; BOLIS G; COLNAGHI MI; DIRE EM; EGGERMONT AMM; GOEY SH; GRATAMA JW; LAMERS CHJ; NOOY MA; PARMIANI G; RASPAGLIESI F; RAVAGNANI F; SCARFONE G; TRIMBOS JB; WARNAAR SO; BOLHUIS RLH
      REGRESSION OF ADVANCED OVARIAN-CARCINOMA BY INTRAPERITONEAL TREATMENTWITH AUTOLOGOUS T-LYMPHOCYTES RETARGETED BY A BISPECIFIC MONOCLONAL-ANTIBODY

      Journal of the National Cancer Institute
    64. SCHUMACHER DL; SACLARIDES TJ; STAREN ED
      PERITONEOVENOUS SHUNTS FOR PALLIATION OF THE PATIENT WITH MALIGNANT ASCITES

      Annals of surgical oncology
    65. FREEDMAN RS; EDWARDS CL; KAVANAGH JJ; KUDELKA AP; KATZ RL; CARRASCO CH; ATKINSON EN; SCOTT W; TOMASOVIC B; TEMPLIN S; PLATSOUCAS CD
      INTRAPERITONEAL ADOPTIVE IMMUNOTHERAPY OF OVARIAN-CARCINOMA WITH TUMOR-INFILTRATING LYMPHOCYTES AND LOW-DOSE RECOMBINANT INTERLEUKIN-2 - A PILOT TRIAL

      Journal of immunotherapy with emphasis on tumor immunology
    66. BAXEVANIS CN; PAPAMICHAIL M
      CHARACTERIZATION OF THE ANTITUMOR IMMUNE-RESPONSE IN HUMAN CANCERS AND STRATEGIES FOR IMMUNOTHERAPY

      Critical reviews in oncology/hematology
    67. SMITH TR
      MALIGNANT PERITONEAL MESOTHELIOMA - MARKED VARIABILITY OF CT FINDINGS

      Abdominal imaging
    68. SUGIMACHI K; MAEHARA Y; AKAZAWA K; KONDO Y; KUNII Y; KITAMURA M; YAMAOKA H; TAKAHASHI Y; KITO T; KATOU M; FURUKAWA H; TAKASHIMA S
      POSTOPERATIVE CHEMOTHERAPY INCLUDING INTRAPERITONEAL AND INTRADERMAL ADMINISTRATION OF THE STREPTOCOCCAL PREPARATION OK-432 FOR PATIENTS WITH GASTRIC-CANCER AND PERITONEAL DISSEMINATION - A PROSPECTIVE RANDOMIZED STUDY

      Cancer chemotherapy and pharmacology
    69. FISK B; FLYTZANES CN; POLLACK MS; WHARTON JT; IOANNIDES CG
      CHARACTERIZATION OF T-CELL RECEPTOR V-BETA REPERTOIRE IN OVARIAN TUMOR-REACTING CD3(-) CTL LINES()CD8(+)CD4()

      Scandinavian journal of immunology
    70. RUNYON BA
      EDITORIAL - MALIGNANCY-RELATED ASCITES AND ASCITIC FLUID HUMORAL TESTS OF MALIGNANCY

      Journal of clinical gastroenterology
    71. INOUE M; KATO H; MUKAI S; KAWAHITO Y; ASAI K; KIMURA S; YAMAMURA Y; SANO H; SUGINO S; KONDO M
      RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AUGMENTS CYTOTOXICITY OF OK-432-INDUCED POLYMORPHONUCLEAR LEUKOCYTES

      International journal of immunopharmacology
    72. SABATELLI FW; GLASSMAN ML; KERNS SR; HAWKINS IF
      PERMANENT INDWELLING PERITONEAL ACCESS DEVICE FOR THE MANAGEMENT OF MALIGNANT ASCITES

      Cardiovascular and interventional radiology
    73. WEI YY; CHUNG C
      ANALYSIS OF ELEMENTAL ABSORPTION AND EXCRETION IN MICE BEARING MALIGNANT ASCITES

      Biological trace element research
    74. JOHANSEN HT; BUO L; KARLSRUD TS; AASEN AO
      DEXTRAN SULFATE ACTIVATION OF THE CONTACT SYSTEM IN PLASMA AND ASCITES

      Thrombosis research
    75. JOHANSEN HT; BUO L; KARLSRUD TS; AASEN AO
      DEXTRAN SULFATE ACTIVATION OF THE CONTACT SYSTEM IN PLASMA AND ASCITES

      Thrombosis research
    76. GERBES AL; SCHOLMERICH J
      CARE OF PATENTS WITH ASCITES

      The New England journal of medicine
    77. OLSON TA; MOHANRAJ D; CARSON LF; RAMAKRISHNAN S
      VASCULAR-PERMEABILITY FACTOR GENE-EXPRESSION IN NORMAL AND NEOPLASTICHUMAN OVARIES

      Cancer research
    78. WARD BG; MCGUCKIN MA
      ARE CASA AND CA125 CONCENTRATIONS IN PERIPHERAL-BLOOD SOURCED FROM PERITONEAL-FLUID IN WOMEN WITH PELVIC MASSES

      Cancer
    79. BAXEVANIS CN; DEDOUSSIS GVZ; GRITZAPIS AD; STATHOPOULOS GP; PAPAMICHAIL M
      INTERLEUKIN-1-BETA SYNERGISES WITH INTERLEUKIN-2 IN THE OUTGROWTH OF AUTOLOGOUS TUMOR-REACTIVE CD8+ EFFECTORS

      British Journal of Cancer
    80. MAEHARA Y; OKUYAMA T; KAKEJI Y; BABA H; FURUSAWA M; SUGIMACHI K
      POSTOPERATIVE IMMUNOCHEMOTHERAPY INCLUDING STREPTOCOCCAL LYSATE OK-432 IS EFFECTIVE FOR PATIENTS WITH GASTRIC-CANCER AND SEROSAL INVASION

      The American journal of surgery
    81. GERBES AL; PAUMGARTNER G
      DIAGNOSIS OF ASCITES

      Deutsche Medizinische Wochenschrift
    82. TSUCHIYA I; KASAHARA T; YAMASHITA K; KO YC; KANAZAWA K; MATSUSHIMA K; MUKAIDA N
      INDUCTION OF INFLAMMATORY CYTOKINES IN THE PLEURAL EFFUSION OF CANCER-PATIENTS AFTER THE ADMINISTRATION OF AN IMMUNOMODULATOR, OK-432 - ROLE OF IL-8 FOR NEUTROPHIL INFILTRATION

      Cytokine
    83. TAKEDA T; KOBAYASHI T; MONDEN T; KATSUMOTO Y; ITO Y; WAKASUGI E; WAKASUGI T; TOMITA N; SHIMANO T; MORI T
      THE EFFECT OF LOCAL IMMUNOTHERAPY FOR BREAST-CANCER USING A MIXTURE OF OK-432 AND FIBRINOGEN SUPPLEMENTED WITH ACTIVATED MACROPHAGES

      Biotherapy
    84. SAKITA I; MONDEN T; NAGAOKA H; KATSUMOTO Y; WAKASUGI T; TOMITA N; TAKEDA T; KOBAYASHI T; SHIMANO T; MORI T
      AUGMENTATION OF ANTITUMOR IMMUNITY IN REGIONAL LYMPH-NODES BY LOCAL IMMUNOTHERAPY

      Biotherapy
    85. SISTERMANNS J; HOFFMANNS HW; DUX A
      INTRAPERITONEAL INFUSION OF RECOMBINANT TUMOR-NECROSIS-FACTOR FOR PALLIATIVE THERAPY OF TERMINALLY ILL PATIENTS WITH REFRACTORY MALIGNANT ASCITES

      Onkologie
    86. BAC DJ; SIERSEMA PD; WILSON JHP
      PARACENTESIS - THE IMPORTANCE OF OPTIMAL ASCITIC FLUID ANALYSIS

      Netherlands journal of medicine
    87. HAGIWARA A; TAKAHASHI T; SAWAI K; SAKAKURA C; TSUJIMOTO H; OSAKI K; SAKAKIBARA T; OHYAMA T; OHGAKI M; MURANISHI S; IKADA Y; HYON SH
      CLINICAL-TRIALS WITH INTRAPERITONEAL CISPLATIN MICROSPHERES FOR MALIGNANT ASCITES - A PILOT-STUDY

      Anti-cancer drug design
    88. PEOPLES GE; SCHOOF DD; ANDREWS JVR; NORTON JA; KIM B; ALEXANDER HR; GOEDEGEBUURE PS; EBERLEIN TJ
      T-CELL RECOGNITION OF OVARIAN-CANCER

      Surgery
    89. BUO L; KARLSRUD TS; DYRHAUG G; JACOBSEN MB; BELL H; JOHANSEN HT; AASEN AO
      DIFFERENTIAL-DIAGNOSIS OF HUMAN ASCITES - INHIBITORS OF THE CONTACT SYSTEM AND TOTAL PROTEINS

      Scandinavian journal of gastroenterology
    90. YEO KT; WANG HH; NAGY JA; SIOUSSAT TM; LEDBETTER SR; HOOGEWERF AJ; ZHOU Y; MASSE EM; SENGER DR; DVORAK HF; YEO TK
      VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IN GUINEA-PIG AND HUMAN TUMOR AND INFLAMMATORY EFFUSIONS

      Cancer research
    91. COLLI A; COCCIOLO M; RIVA C; MARCASSOLI L; PIROLA M; DIGREGORIO P; BUCCINO G
      ASCITIC FLUID ANALYSIS IN HEPATOCELLULAR-CARCINOMA

      Cancer
    92. NAGY JA
      LYMPHATIC AND NONLYMPHATIC PATHWAYS OF PERITONEAL ABSORPTION IN MICE - PHYSIOLOGY VERSUS PATHOLOGY

      Blood purification


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 20:55:44